Braidwell »

Biontech Se shares owned by Braidwell

Quarter-by-quarter ownership of Biontech Se (BNTX) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Biontech Se

Tip: Access up to 7 years of quarterly data

All positions including Biontech Se held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biontech Se by Braidwell

Quarter filed Position value Share count Share price at filing
2024-09-30 $29M 248k 118.77

More positions owned by Braidwell

Guardant Health Note11/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Novocure Note11/0 (Principal)
Cg Oncology (CGON)
Nuvasive Note 0.375% 3/1 (Principal)
Xenon Pharmaceuticals (XENE)
Neurocrine Biosciences (NBIX)
Neogenomics Note 0.250% 1/1 (Principal)
Apogee Therapeutics (APGE)
Apellis Pharmaceuticals (APLS)
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)
Dexcom Note 0.375% 5/1 (Principal)
Align Technology (ALGN)
Guardant Health (GH)
Insulet Corp Note 0.375% 9/0 (Principal)

View all positions for Braidwell

Top funds holding Biontech Se

Baillie Gifford & Co
PRIMECAP Management Company
Flossbach Von Storch
Harding Loevner
BlackRock
BlackRock
Morgan Stanley
Citadel Advisors
Capital Research and Management Company - Division 3
Capital International
Susquehanna International
Quinn Opportunity Partners
Altrinsic Global Advisors
Candriam Luxembourg S.C.A.
Jane Street

View all funds holding Biontech Se